Chairman:  Joe Pitts (PA-16)
Public health and quarantine; hospital construction; mental health; biomedical research and development; health information technology, privacy, and cybersecurity; public health insurance (Medicare, Medicaid) and private health insurance; medical malpractice and medical malpractice insurance; the regulation of food, drugs, and cosmetics; drug abuse; the Department of Health and Human Services; the National Institutes of Health; the Centers for Disease Control; Indian Health Service; and all aspects of the above-referenced jurisdiction related to the Department of Homeland Security.



Joe Pitts (PA), Chairman
Brett Guthrie (KY), Vice Chairman
Ed Whitfield (KY)
John Shimkus (IL)
Tim Murphy (PA)
Michael C. Burgess, M.D. (TX)
Marsha Blackburn (TN)
Cathy McMorris Rodgers (WA)
Leonard Lance (NJ)
Morgan Griffith (VA)
Gus Bilirakis (FL)
Billy Long (MO)
Renee Ellmers (NC)
Larry Bucshon (IN)
Susan Brooks (IN)
Chris Collins (NY)
Joe Barton (TX)
Fred Upton (MI) (Ex Officio)


Gene Green (TX), Ranking Member
Eliot L. Engel (NY)
Lois Capps (CA)
Jan Schakowsky (IL)
G. K. Butterfield (NC)
Kathy Castor (FL)
John Sarbanes (MD)
Doris O. Matsui (CA)
Ben Ray Lujan (NM)
Kurt Schrader (OR)
Joseph P. Kennedy, III (MA)
Tony Cardenas (CA)
Frank Pallone, Jr. (NJ) (Ex Officio)

April 25, 2014 | Press Release

WASHINGTON, DC – The House Energy and Commerce Committee today announced its hearing and vote schedule for the week of April 28, 2014. The committee will examine the growing concerns regarding prescription drug and heroin abuse, continue its review of the Chemicals in Commerce Act, and discuss and how 21st century technology can benefit patients.

April 24, 2014 | Press Release

The Subcommittee on Health, chaired by Rep. Joe Pitts (R-PA), has scheduled a hearing for Thursday, May 1, 2014, at 10 a.m. in room 2123 of the Rayburn House Office Building. The hearing is entitled “Telehealth to Digital Medicine: How 21st Century Technology Can Benefit Patients.” Witnesses to be announced.

April 22, 2014 | Letter

Excerpt: The process followed by FDA in proposing this rule appears to stand in stark contrast to the approach taken by the agency in developing changes to the content and format of prescription drug labeling under the Clinton administration.

April 22, 2014 | Press Release

WASHINGTON, DC – House Energy and Commerce Committee members today sent a letter to Food and Drug Administration Commissioner Margaret Hamburg, M.D. expressing their concerns regarding the administration’s proposed changes to generic drug labeling.

April 17, 2014 | Press Release

WASHINGTON, DC – House Energy and Commerce Committee Chairman Fred Upton (R-MI) issued the following statement regarding the administration’s latest health law data release.

April 15, 2014 | ICYMI

Upton: “Did the health law work to insure the uninsured? A simple check of the box could answer that question. Sadly, we may never know – and the administration seems just fine with that.”